EFFECT OF PLANT REMEDY «BRAIN-PROPHYT» ON SPATIAL MEMORY IN RATS WITH BRAIN ISCHEMIA

The aim of the research. Determination of the effect of the plant extract «Brain-Profit» on spatial memory in rats using the cerebral ischemia model.
Materials and methods. The experiments were conducted on male Wistar rats.The first group consisted of sham-operated rats, the second group consisted of rats with cerebral ischemia, and the third and fourth groups consisted of rats with cerebral ischemia that received «Brain-profit» (100 mg/kg) and standardized Ginkgo biloba extract (50 mg/ kg) (EGb), respectively.
The effect of the extract on spatial memory in rats was evaluated using the 8-arm maze method.
Pathomorphological studies of rat brain samples were performed using light microscopy.
The brain content of bdnf was determined using the ELISA method. The antioxidant status was studied in brain tissue by the activity of antioxidant enzymes – superoxidismutase (SOD), catalase, and the content of lipoperoxidation products – malodialdehyde (MDA).
Results. The administration of the extract to rats with brain ischemia had a nootropic effect: the number of errors in reference and working memory was 2,9 and 6,5 times lower, respectively, compared to the control. In the morphological study, the degree of hippocampal damage was less in the experienced rats compared to the control.
Administration of «Brain-profit» and Egb to rats increased the content of bdnf in the hippocampus by 48% and 28%, respectively, compared to the control.
The SOD and catalase activities were 82% and 36% higher, respectively, and MDA content was 30% and 32% lower, respectively, compared to the control.
Conclusion. The «Brain-profit» has a positive effect on spatial memory in rats with cerebral ischemia. The extract increases the content of bdnf in the hippocampus, enhances the antioxidant potential, and prevents neuronal damage. The nootropic effect of the extract is due to the neurotrophic, neuroprotective, and antioxidant actions of the biologically active substances.

1. Gulyaev S.A., Ovchinnikov A.V., Arkhipenko I.V. "Asymptomatic" Stenoses of the Major Arteries of the Head and Their Impact on the Bioelectric Activity of the Brain. Difficult Patient. 2012. 12 (10). 18–21. (in Russian).

2. Travica N., Aslam H., O'Neil A., et al. Brain derived neurotrophic factor in perioperative neurocognitive disorders: Current evidence and future directions.Neurobiol Learn Mem. 2022. Sep. 193: 107656. doi: 10.1016/j.nlm.2022.107656. Epub 2022 Jul 2. PMID: 35792324.

3. Pisani A., Paciello F., Del Vecchio V. et al. The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration. J Pers Med. 2023 Apr. 10. 13 (4). 652. doi: 10.3390/jpm13040652. PMID: 37109038; PMCID: PMC10140880.

4. Bramham C.R., Messaoudi E. BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis. Prog. Neurobiol. 2005. 76. 99–125.

5. Gulyaev S.M., Turtueva T.A., Nikolaeva, G.G. Evaluation of the Antioxidant Activity and AntiInflammatory Effect of Root Extracts of Astragalus Membranaceus, ScutellariaBaicalensis, and PhlojodicarpusSibiricus.Pharm Chem J. 2023. 57. 378-81. https://doi.org/10.1007/s11094-023-02893-2 (in Russian).

6. Gulyaev S.M., Zhalsanov Yu.V., Turtueva T.A., Nikolaeva G.G. Chemical composition of the extract from the roots of Astragalus membranaceus, Scutellariabaicalensis, Phlojodicarpussibiricus and its antihypoxic activity.Butlerov Communications. 2022. 71 (9). 70–5. (in Russian).

7. Moosavi F., Hosseini R., Saso L., Firuzi O. Modulation of neurotrophic signaling pathways by polyphenols. Drug Des DevelTher. 2015. Dec. 21. 10. 23–42. doi: 10.2147/DDDT.S96936. PMID: 26730179; PMCID: PMC4694682.

8. Nikolaev S.M., Nikolaeva G.G., Nikolaeva I.G. et al. Method for producing a product with anti-ischemic and antioxidant activity. Patent for invention. 2603465 C1, 27.11.2016. Application No. 2015140636/15 dated 23.09.2015. (in Russian).

9. Mirzoyan R.S., Saratikov A.S., Plotnikov A.V., Topchyan A.V., Ganshina T.S. Guidelines for the experimental study of drugs for the treatment of cerebrovascular disorders and migraines. In: Khabriev R.U., editor. Guidelines for the Experimental (Preclinical) Study of New Pharmacological Substances. Moscow. Medicine. 2005. p. 332–338 (in Russian).

10. Buresh Ya., Bureshova O., Houston D. P. Methods and basic experiments in the study of the brain and behavior. M. 1991.

11. Gulyaev S.M., Nikolaev S.M., Tulonov M.Yu., Serebryanskaya T.V. Influence of dry polyextract on cognitive functions in rats with brain ischemia. Far Eastern Medical Journal. 2012. 2. 102–4. (in Russian).

12. Sarkisov D.S., Perov Yu.L., editors. Microscopic Technique: A Guide. Moscow. 1996. (in Russian).

13. Stalnaya I.D., Garishvili T.G. The method of determination of malonic dialdehyde by thiobarbituric acid. Modern methods in biochemistry.OrekhovichV,N., editor. M. Medicine. 1977. (in Russian).

14. Sokolov S.Ya., Zamotaev I.P. Handbook on medicinal plants : phytotherapy. 3rd ed. Moscow. Medicine, 1990. (in Russian).

15. Gulyaev S.M. Vascular and molecular-cellular mechanisms of cognitive disorders development after carotid artery occlusion. Angiology and vascular surgery. 2021. 27 (2). 11–16. (in Russian).

16. Ni G.X, Liang C., Wang J., et al. Astragaloside IV improves neurobehavior and promotes hippocampal neurogenesis in MCAO rats though BDNF-TrkB signaling pathway. Biomed Pharmacother. 2020. Oct. 130: 110353. doi: 10.1016/j.biopha.2020.110353. Epub 2020 Jul 16. PMID: 32682983.

17. Wang P., Wang Z., Zhang Z., et al. A review of the botany, phytochemistry, traditional uses, pharmacology, toxicology, and quality control of the Astragalus memeranaceus. Front Pharmacol. 2023. Aug. 23.14:1242318.doi: 10.3389/fphar.2023.1242318. PMID: 37680711; PMCID: PMC10482111.

18. Yu H., Chen B., Ren Q. Baicalin relieves hypoxia-aroused H9c2 cell apoptosis by activating Nrf2/HO-1-mediated HIF1α/BNIP3 pathway. Artif Cells NanomedBiotechnol. 2019. Dec.; 47 (1). 3657-63.doi: 10.1080/21691401.2019.1657879.

19. Pan L., Cho K.S., Yi I., et al. Baicalein, Baicalin, and Wogonin: Protective Effects against IschemiaInduced Neurodegeneration in the Brain and Retina. Oxid Med Cell Longev. 2021. Jun. 29. 2021.8377362. doi: 10.1155/2021/8377362. PMID: 34306315; PMCID: PMC8263226.

20. Li C., Sui C., Wang W., et al. Baicalin Attenuates Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury by Modulating the BDNF-TrkB/PI3K/Akt and MAPK/Erk1/2 Signaling Axes in Neuron-Astrocyte Cocultures. Front Pharmacol. 2021. Jun. 2.12.599543. doi: 10.3389/fphar.2021.599543. PMID: 34234667; PMCID: PMC8255628.